Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AspirinTBM
NCT02237365Phase 2Completed
- Sponsor
- Oxford University Clinical Research Unit
- Start
- Oct 2014
- Primary completion
- Jun 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of aspirin in tuberculous meningitis (TBM) (3 arms), sponsored by Oxford University Clinical Research Unit. Primary endpoints: Number of episodes of either cerebral bleeding or clinically significant upper-gastro-intestinal bleeding at 60 days and Number of episodes of MRI-proven brain infarction or death at 60 days. Started Oct 2014; status: completed.
02
Drugs
aspirin
03
Conditions
tuberculous meningitis (TBM)
Beyond the preview
Go deeper on NCT02237365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02237365.